The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
about
The Efficacy and Immunomodulatory Effects of Ulinastatin and Thymosin α1 for Sepsis: A Systematic Review and Meta-AnalysisIs boosting the immune system in sepsis appropriate?Current epidemiology of sepsis in mainland ChinaImmunotherapy - a potential new way forward in the treatment of sepsisRole of circulating lymphocytes in patients with sepsis.Therapeutic interventions in sepsis: current and anticipated pharmacological agentsYear in review 2013: Critical Care--sepsis.The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.Critical care medicine 2013: a review and prospectImmunomodulatory adjuvant therapy in severe community-acquired pneumonia.Historical review of thymosin α 1 in infectious diseases.Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.Misdirected Sympathy.Sepsis: frontiers in supportive care, organisation and research.Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort studyEvaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis.Expert consensus on the perioperative management of patients with sepsis.Is this critically ill patient immunocompromised?Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure.Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation
P2860
Q26747196-4DBD10A4-1869-472B-A184-0333FF1BE81AQ27691996-278AA2B4-A726-4339-8428-8D46EE276F8DQ28074598-7CF45CAB-270D-40B9-8560-B7B91AFDB34AQ33749999-B1FACFD6-3F55-47B2-817B-89F8C05E3FB9Q34177314-6B1ABFB4-5BAF-44F8-BAD6-048FA0CC78FBQ34427050-54982570-9626-4493-AB58-4AEBE83983C7Q35091080-C99DD8B9-4486-4A65-A7A7-AEDDB3B94E72Q36135093-5D5BA7F2-5C77-44E4-AF55-7CB027D02F3DQ38177276-12A36FFB-4EAF-4733-8227-AB365C946E2CQ38217723-64877993-8C74-48DD-B294-21D4DF294B84Q38534271-ED1E8436-7F6D-4DBE-9212-7D0497F345F3Q38541110-AE0DCD6A-6D95-4682-A80D-9F907BFEAADEQ38763684-82BD2936-8465-40D7-AF95-C09DB5CE2A5DQ38764864-D5F7F189-D94E-47E5-8B5D-D9152C7510D5Q38801190-A60F5756-68A7-4F81-9C76-CEF5D648EB81Q41509426-1B06EC49-831B-48FE-935C-7D673290568DQ42087444-27A0ACE2-4702-421E-A8DE-1990A2CFA124Q51568615-AF55C01F-9F59-453B-AEEA-51AFAFAE2D02Q52579155-53D69C6B-7BE3-4D3F-9482-6964B72586D4Q52653082-DD3B4A52-B322-4AFD-A22F-AED53A98C2FAQ59136322-C50C8F77-7D1A-4ACF-AAFE-BDA4F76D3967
P2860
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@ast
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@en
type
label
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@ast
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@en
prefLabel
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@ast
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@en
P2093
P2860
P356
P1433
P1476
The efficacy of thymosin alpha ...... ndomized and controlled trial.
@en
P2093
Baochun Gu
Bin Ou-Yang
Guanrong Zhang
Jianfeng Wu
Lixin Zhou
P2860
P2888
P356
10.1186/CC11932
P577
2013-01-17T00:00:00Z
P5875
P6179
1008077796